Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 31181
Hepatotoxicity Induced by Arsenic Trioxide in Adult Mice and Their Progeny

Authors: H. Bouaziz, N. Soudania, M. Essafia, I. Ben Amara, A. Hakim, K. Jamoussi, Km. Zeghal, N. Zeghal

Abstract:

In this investigation, we have evaluated the effects of arsenic trioxide on hepatic function in pregnant and lactating Swiss albino mice and their suckling pups. Experiments were carried out on female mice given 175 ppm As2O3 in their drinking water from the 14th day of pregnancy until day 14 after delivery. Our results showed a significant decrease in plasma levels of total protein and albumin, cholesterol and triglyceride in As2O3 treated mice and their pups. The hyperbilirubinemia and the increased plasma total alkaline phosphatase activity suggested the presence of cholestasis. Transaminase activities as well as lactate deshydrogenase activity in plasma, known as biomarkers of hepatocellular injury, were elevated indicating hepatic cells’ damage after treatment with As2O3. Exposure to arsenic led to an increase of liver thiobarbituric acid reactive substances level along with a concomitant decrease in the activities of superoxide dismutase, catalase and glutathione peroxidase and in glutathione.

Keywords: mice, Oxidative Stress, hepatotoxicity, antioxidant status, arsenic trioxide

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1099539

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 2051

References:


[1] R. Gupta, G.M. Kannan, M. Sharma, and S.J.S. Flora, “Therapeutic effects of Moringa oleifera on arsenic-induced toxicity in rats.” Environmental Toxicology and Pharmacology, vol. 20, pp. 456-464, 2005.
[2] Y. Jin, G. Sun, X. Li, G. Li, C. Lu, and L. Qu, “Study on the toxic effects induced by different arsenicals in primary cultured rat astroglia.” Toxicology and Applied Pharmacology, vol. 196, pp. 396–403, 2004.
[3] C.H. Tseng, C.K. Chong, C.J. Chen, and T.Y. Tai, “Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in Blackfoot disease endemic villages in Taiwan.” Atherosclerosis, vol. 120, pp. 125–133, 1996.
[4] C.J. Chen, Y.M. Hsueh, M.S. Lai, M.P. Shyu, S.Y. Chen, M.M. Wu, T.L. Kuo, and T.Y. Tai, “Increased prevalence of hypertension and long term arsenic exposure.” Hypertension, vol. 25, pp. 53–60, 1995.
[5] P.P. Simeonova, and M.I. Luster, “Arsenic and atherosclerosis.” Toxicology and Applied Pharmacology, vol. 198, pp. 444–449, 2004.
[6] R. Iffland, D. Seiler, G. Hans, A. Siegel, and H. Siegal, “Handbook on metals in clinical and analytical chemistry.” New York: Marcel Dekkar, Inc, 1994, pp. 237–253.
[7] Z. Li, F. Piao, S. Liu, Y. Wang, and S. Qu, “Subchronic exposure to arsenic trioxideinduced oxidative DNA damage in kidney tissue of mice.” Experimental and Toxicologic Pathology, vol. 62, pp. 543–547, 2010.
[8] G.K. Harris, and X. Shi, “Signalling by carcinogenic metals and metalinduced reactive oxygen species.” Mutation Research, vol. 533, pp. 183– 200, 2003.
[9] G. Concha, G. Vogler, D. Lezcano, B. Nermell, and M. Vahter, “Exposure to inorganic arsenic metabolites during early human development.” Toxicology Sciences, vol. 44, pp. 185–90, 1998.
[10] V. Devesa, B.M. Adair, J. Liu, M.P. Waalkes, B.A. Diwan, M. Styblo, and D.J. Thomas, “Arsenicals in maternal and foetal mouse tissues after gestational exposure to arsenite.” Toxicology, vol. 224, pp. 147–55, 2006.
[11] V.H. Ferm, and S.J. Carpenter, “Malformations induced by sodium arsenate.” Journal of Reproduction and Fertility, vol. 17, pp. 199-201, 1967.
[12] R.D. Hood, “Effects of sodium arsenite on foetal development.” Environmental Contamination and Toxicology, vol. 7, pp. 216-222, 1972.
[13] A.R. Beaudoin, “Teratogenicity of sodium arsenate in rats.” Teratology, vol. 10, pp. 153-158, 1974.
[14] M.P. Waalkes, J.M. Ward, J. Liu, and B.A. Diwan, “Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice.” Toxicol Appl Pharmacol, vol. 186, pp. 7–17, 2003.
[15] M.P. Waalkes, J. Liu, J.M. Ward, D.A. Powell, and B.A. Diwan, “Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment.” Cancer Research, vol. 66, pp. 1337–1345, 2006.
[16] A.H. Smith, G. Marshall, Y. Yuan, C. Ferreccio, J. Liaw, E.O. von, C. Steinmaus, M.N. Bates, and S. Selvin, “Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood.” Environmental Health Perspectives, vol. 114, pp. 1293–1296, 2006.
[17] G. Tournel, V. Gnemmi, and V. Hédouin, “Acute arsenic poisoning: clinical, toxicological, histopathological, and forensic features.” Journal of Forensic Sciences, vol. 56, pp. 275–279, 2011.
[18] J.W.E. Harrison, E.W. Packman, and D.D. Abbott, “Acute oral toxicity and chemical and physical properties of arsenic trioxides.” American Medical Association Archives of Industrial Health, vol. 17, pp. 118-123, 1958.
[19] K.L. Fishbeck, and K.M. Rasmussen, “Effects of repeated cycles on maternal nutritional status, lactational performance and litter growth in ad libitum-fed and chronically food-restricted rats.” The Journal of Nutrition, vol. 117, pp. 1967–1975, 1987.
[20] H.H. Draper, and M. Hadley, “Malondialdehyde determination as index of lipid peroxidation.” Methods in Enzymology, vol. 86, pp. 421-431, 1990.
[21] C. Beauchamp, and I. Fridovich, “Superoxide dismutase: improved assays and an assay applicable to acrylamide gel.” Analytical Biochemistry, vol. 44, pp. 276–287, 1971.
[22] H. Aebi, “Catalase in vitro.” Methods in Enzymology, vol. 105, pp. 121- 126, 1984.
[23] L. Flohe, and W.A. Gunzler, “Assays of glutathione peroxidase.” Method Enzymol, vol. 105, pp. 114-121, 1984.
[24] G.L. Ellman, “Tissue sulfhydryl groups.” Archives of Biochemistry and Biophysics, vol. 82, pp. 70-77, 1959.
[25] D.J. Jollow, J.R. Mitchell, N. Zampaglione, and J.R. Gillette, “Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite.” Pharmacology, vol. 11, pp. 151-169, 1974.
[26] C. Watanabe, T. Inaoka, T. Mastui, K. Ishigaki, N. Murayama, and R. Ohtsuka. Effects of arsenic on younger generations. Journal of Environmental Science and Health, vol. 38, pp. 129-139, 2003.
[27] D.N. Guha Mazumder, “Effect of chronic intake of arsenic contaminated water on liver.” Toxicology and Applied Pharmacology, vol. 206, pp. 169–175, 2005.
[28] M. Messarah, F. Klibet, A. Boumendjel, C. Abdennour, N. Bouzerna, M.S. Boulakoud, and A. El Feki, “Hepatoprotective role and antioxidant capacity of selenium on arsenic-induced liver injury in rats.” Experimental and Toxicologic Pathology, vol. 64(3):pp. 167-74, 2012.
[29] N.J. Chinoy, and M.R. Memon, “Beneficial effects of some vitamins and calcium on fluoride and aluminium toxicity on gastrocnemius muscle and liver of male mice.” Fluoride, vol. 34, pp. 21–33, 2001.
[30] S. Pal, and A.K. Chatterjee, Protective effect of N-acetylcysteine against arsenic-induced depletion in vivo of carbohydrate.” Drug and Chemical Toxicology, vol. 27, pp. 179–189, 2004.
[31] S. Pal, and A.K. Chatterjee, “Prospective protective role of melatonine against arsenic-induced metabolic toxicity in Wistar rats.” Toxicology, vol. 208, pp. 25-33, 2005.
[32] Y. Hu, L. Su, and E.T. Snow, “Arsenic toxicity is enzyme specific and its effects on ligation are not caused by the direct inhibition of DNA repair enzymes.” Mutation Research, vol. 408, pp. 203–218, 1998.
[33] E. Lenartowicz, “A complex effect of arsenite on the formation of alphaketoglutarate in rat liver mitochondria.” Archives of Biochemistry and Biophysics, vol. 283, pp. 388–396, 1990.
[34] A.K. Patlolla, C. Barnes, C. Yedjou, V.R. Velma, and P.B. Tchounwou, “Oxidative stress, DNA damage, and antioxidant enzyme activity induced by hexavalent chromium in sprague-dawley rats.” Environmental Toxicology, vol. 24, pp. 66-73, 2009.
[35] F.M. El-Demerdash, M.I. Yousef, and F.A. Elaswad, “Biochemical study on the protective role of folic acid in rabbits treated with chromium (VI).” Journal of Environmental Science and Health, Part B, vol. 41, pp. 731–746, 2006.
[36] C.L. Gaskill, L.M. Miller, J.S. Mattoon, W.E. Hoffmann, S.A. Burton, H.C.J. Gelens, S.L. Ihle, J.B. Miller, D.H. Shaw, and A.E. Cribb, “Liver histopathology and liver serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving Phenobarbital.” Veterinary Pathology, vol. 42, pp. 147-160, 2005.
[37] A. Albores, M.E. Cebria´n, P.H. Bach, J.C. Connelly, R.H. Hinton and J.M. Bridges, “Sodium arsenite induced alterations in bilirubin excretion and heme metabolism.” Journal of Biochemical Toxicology, vol. 4, pp. 73–78, 1989.
[38] A. Hernandez-Zavala, L.M. Del Razo, C. Aguilar, G.G. Garcia-Vargas, V.H. Borja, and M.E. Cebrian, “Alteration in bilirubin excretion in individuals chronically exposed to arsenic in Mexico.” Toxicology Letters, vol. 99, pp. 79-84, 1998.
[39] S. Das, A. Santra, S. Lahiri, and D.N. Guha Mazumder, “Implications of oxidative stress and hepatic cytokine (TNF-alpha and IL-6) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity.” Toxicology and Applied Pharmacology, vol. 204, pp. 18–26, 2005.
[40] S.X. Liu, M. Athar, I. Lippai, C. Waldren, and T.K. Hei, “Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity.” Proceedings of the National Academy of Sciences USA, vol. 98, pp. 1643–1648, 2001.
[41] K.T. Yamanaka, R. Sawamura, A. Hasegawa, and S. Okada, “Induction of DNA damage by dimethyl arsine, a main metabolite of inorganic arsenics, is for the major part due to its peroxyl radical.” Biochemical and Biophysical Research Communications, vol. 168, pp. 58–64, 1989.
[42] N.J. Chinoy, and S.D. Shah, “Biochemical effects of sodium fluoride and arsenic trioxide and their reversal in brain of mice.” Fluoride, vol. 37, pp. 80-87, 2004.
[43] S. Maiti, and A.K. Chatterjee, “Effects in levels of glutathione and some related enzymes in tissues after an acute arsenic exposure in rats and their relationship to dietary protein deficiency.” Archives of Toxicology, vol. 75, pp. 531-537, 2001.
[44] S.J.S. Flora, “Arsenic-induced oxidative stress and its reversibility.” Free Radical Biology and Medicine, vol. 51, pp. 257–281, 2011.
[45] G. Saxena, and S.J.S. Flora, “Lead induced oxidative stress and haematological alterations and their response to combined administration of calcium disodium EDTA with a thiol chelator in rats.” Journal of Biochemical and Molecular Toxicology, vol. 18, pp. 221– 233, 2004.
[46] R. Gupta, G.M. Kannan, M. Sharma, and S.J.S. Flora, “Therapeutic effects of Moringa oleifera on arsenic-induced toxicity in rats.” Environmental Toxicology and Pharmacology, vol. 20, pp. 456-464, 2005.
[47] M.N. Kirkman, and G.F. Gaetani, “Catalase: a tetrameric enzyme with four tightly bound molecules of NADPH. Proceedings of the National Academy of Sciences USA, vol. 81, pp. 4343–4347, 1984.
[48] F. Nielson, “Other trace elements.” In: Ziegler, E.E., Filer, L.J. (Eds.), Present Knowledge in Nutrition, seventh ed. Washington, DC: ILSI Press, 1995, pp. 353–377.